Archean Chemical Industries (ACI) Q4 24/25 earnings summary

Executive summary

• Demonstrated resilience amid global demand variations, with operational improvements and margin maintenance despite industry headwinds.

• FY25 standalone revenue reached Rs. 10,634 million, with exports contributing 77% of operating revenue and a strong client base of 74 customers globally and domestically.

• Strategic investments in bromine derivatives, semiconductors, and energy storage, including Idealis Chemicals, Clas-Sic Wafer Fab, SiCSem Private Limited, and Offgrid Energy Labs, support diversification and long-term growth.

• Acquisition of Oren Hydrocarbons (now Idealis Mudchemie Private Limited) as a step-down subsidiary, consolidated from July 2024.

• Audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, were approved, with unmodified audit opinions from statutory auditors.

Financial highlights

• FY2025 standalone revenue: Rs. 10,634.5 million; EBITDA: Rs. 3,721.2 million (35% margin); Net profit: Rs. 1,849.2 million; Basic EPS: Rs. 15.0.

• FY2025 consolidated revenue: Rs. 10,410.179 million; consolidated net profit: Rs. 1,621.449 million; consolidated EPS: Rs. 13.13.

• Export markets contributed 77% of FY2025 revenue.

• Final dividend of Rs. 3 per equity share recommended for FY2025.

• FY25 revenue and profit declined year-over-year, but ROCE increased to 20.5% and ROE to 10.3%.

Outlook and guidance

• Targeting bromine sales volumes of 22,000–25,000 tons for FY2026, with increased captive consumption.

• Industrial salt volume guidance for FY2026: 4.5–5 million tons, leveraging expanded capacity.

• Strategic focus on semiconductor initiatives and entry into the energy storage segment through investments.

• Expecting Oren Hydrocarbons to contribute Rs. 1,500 million in FY2026 revenue.

• Anticipate meaningful sulfate of potash contributions from H2 FY2026.